Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación
Artículo científico (JournalArticle)
Mitochondrial transplantation as a new therapeutic approach against cardiac and renal consequences in male rats with myocardial infarction
Aim: Myocardial infarction (MI) is one of the leading causes of death worldwide. MI is associated with cardiac structural and
functional alterations. Among these, cardiac fibrosis may be significantly influenced by mitochondrial dysfunction. We sought
to evaluate whether the injection of functional mitochondria from healthy muscle could improve the detrimental consequences
of MI. Methods: Male Wistar rats were submitted to MI through the ligature of the left anterior descending coronary artery. Animals
subjected to a sham operation (the same surgical procedure without fastening of the suture that passes through the LAD) were
included as a reference group (Sham). At the time of surgery, either vehicle (PBS) or isolated mitochondria (equivalent to 180μg
of mitochondrial protein in 75μL of vehicle) were directly injected into the myocardium around the ligation to half of the animals
in each group. Animals were sacrificed 4weeks after both MI induction and the evaluation of cardiac and systolic functions. Results: Cardiac mitochondrial transplantation was able to prevent the decrease in systolic function and the development of
cardiac fibrosis in MI rats. These beneficial effects were accompanied by a reduction in cardiac hypertrophy, oxidative stress,
endoplasmic reticulum stress activation, and inflammatory markers. We also evaluated the effects of mitochondrial transplantation by a proteomic analysis. In addition, cardiac mitochondrial transplantation was able to prevent the development of renal
alterations observed in MI rats. Conclusions: The data reveal novel mechanisms of mitochondrial transplantation effects and emerge as a novel therapeutic
strategy under chronic diseases such as MI., This work was supported by Instituto de Salud Carlos III-Fondo Europeode Desarrollo Regional (FEDER) (PI21/00431 and CIBERCV). M.C.-C.was supported by a contract from Universidad Complutense de Madridy Banco Santander (CT15/23). A.M.-G. was supported by a contract fromCAM (Ayuda de empleo juvenil CT41/22/PEJ-2021-AI/BMD-22002)